I argued with the father of open source for 2 years. Now the AI fight is the same — only bigger

Two Sigma co-founder David Siegel says closing off AI is the same mistake the software industry nearly made in the 1980s — ...

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.